Using clinically annotated breast cancer gene expression datasets, we found that the percentage of cases with ANLN mRNA upregulation is significantly higher in TNBC as compared to luminal breast tumors (Fig. 6a). This evidence concerns the gene ANLN and breast neoplasm.